human
enterovirus
hev
belong
picornavirida
famili
ubiquit
virus
respons
wide
rang
clinic
syndrom
rang
mild
respiratori
symptom
seriou
condit
includ
asept
mening
enceph
acut
flaccid
paralysi
serotyp
support
respiratori
infect
confirm
respons
bronchopneumonia
occasion
fatal
case
mani
rna
virus
genet
evolut
hev
occur
time
mean
point
mutat
recombin
phenomena
allow
viru
adapt
environ
modif
host
select
pressur
genet
evolut
link
directli
virul
characterist
tissu
tropism
henc
pathogen
potenti
virus
differ
serotyp
non
polio
enterovirus
recogn
recent
two
new
enteroviru
classifi
within
hev
speci
c
report
associ
respiratori
diseas
identifi
switzerland
later
countri
often
associ
respiratori
sign
molecularli
identifi
nose
throat
swab
sampl
collect
june
june
children
enrol
cohort
studi
influenzalik
ill
nicaragua
case
also
associ
enter
symptom
identif
novel
hev
anoth
speci
c
hev
distantli
relat
retriev
rectal
swab
deceas
patient
outbreak
flaccid
paralysi
congo
sampl
polioviru
neurolog
enter
respiratori
viral
pathogen
detect
global
distribut
current
unknown
studi
perform
yet
evalu
epidemiolog
featur
infect
furthermor
extens
screen
differ
patient
popul
differ
clinic
syndrom
need
establish
full
spectrum
diseas
associ
evalu
pathogenet
potenti
studi
look
presenc
respiratori
sampl
two
patient
popul
infant
less
year
old
hospit
acut
respiratori
tract
diseas
ard
ii
adult
immunosuppress
hematopoiet
stem
cell
transplant
recipi
sequenti
nasopharyng
aspir
evalu
respiratori
sampl
obtain
infant
age
rang
month
mean
age
month
hospitalis
octob
novemb
evalu
presenc
diagnosi
admiss
lower
acut
respiratori
diseas
lard
patient
bronchiol
bronchiti
bronchopneumonia
upper
respiratori
tract
diseas
urtd
includ
rhiniti
laryng
upper
respiratori
tract
phlogosi
remain
patient
sampl
infant
test
posit
rna
belong
patient
diagnos
lard
two
posit
children
month
old
sampl
collect
novemb
januari
clinic
featur
posit
infant
report
tabl
coinfect
viral
pathogen
observ
case
particular
one
case
hrv
also
identifi
posit
case
tripl
infect
observ
rsv
hrv
sampl
taken
octob
septemb
also
evalu
presenc
rsv
hmpv
hcov
hbov
wu
ki
polyomavirus
genom
previou
studi
sampl
period
posit
rsv
rna
hmpv
rna
hcov
rna
hbov
dna
consid
evalu
epidem
period
preval
result
viru
circul
rsv
epidem
peak
contemporarili
hmpv
hcov
transplant
recipi
group
one
sampl
evalu
test
posit
infect
particular
presenc
document
sampl
collect
day
transplant
februari
sixteen
patient
suffer
episod
upper
respiratori
symptom
studi
rhinorrhea
pharingodinia
tussi
patient
sampl
collect
sampl
collect
respiratori
symptom
posit
patient
refer
upper
respiratori
symptom
includ
pharingodinia
last
sever
day
gastrointestin
symptom
record
attempt
identifi
coinfect
virus
includ
hrvc
strain
posit
sampl
gave
neg
result
notabl
three
amplif
protocol
includ
hrv
amplif
protocol
use
degener
primer
amplifi
rhinoviru
theoret
also
sever
picornavirus
suggest
sequenc
align
unpublish
observ
use
present
studi
abl
detect
infect
distinct
agaros
gel
electrophoresi
pattern
sequenc
individu
gel
extract
amplicon
allow
exclud
transplant
recipi
sampl
confirm
pediatr
sampl
coinfect
hrv
tabl
unfortun
low
number
posit
sampl
could
allow
reliabl
statist
analysi
sever
infect
coinfect
comparison
respiratori
virus
popul
describ
previou
paper
recent
identifi
pathogen
analysi
base
along
utr
sequenc
figur
genbank
access
number
indic
compar
three
identifi
strain
result
almost
ident
less
nucleotid
differ
nicaraguan
strain
result
differ
nucleotid
amino
acid
sequenc
respect
compar
strain
figur
februari
novel
identifi
symptomat
immunocompromis
adult
respiratori
sampl
collect
itali
first
report
viru
transplant
patient
respiratori
symptom
retrospect
evalu
carri
pediatr
depart
geograph
area
throughout
period
six
year
prove
infant
two
year
old
hospitalis
ard
circul
low
concentr
period
novemb
suggest
newli
identifi
enteroviru
may
caus
sporad
epidem
northern
itali
sequenc
analysi
perform
base
along
utr
region
show
differ
nucleotid
sequenc
strain
compar
nicaragua
strain
utr
amplifi
region
cross
put
area
recombin
observ
limit
variabl
observ
suggest
recombin
old
strain
circul
worldwid
result
may
point
toward
possibl
role
viru
copathogen
ard
infant
fact
paediatr
case
studi
even
coinfect
detect
sampl
infant
lard
moreov
observ
low
differ
amino
acid
sequenc
isol
studi
describ
nicaragua
symptomat
patient
howev
must
underl
sinc
pediatr
sampl
infant
lower
tract
diseas
exclud
popul
bia
observ
case
infect
larger
studi
need
definit
clarifi
point
fact
singl
infect
observ
pediatr
patient
limit
number
case
allow
statist
signific
comparison
coinfect
sever
compar
neg
coinfect
describ
previou
paper
pathogen
tediou
pharingodinia
suffer
adult
immunocompromis
patient
isol
absenc
coinfect
respiratori
virus
suggest
direct
pathogenet
role
viru
specul
initi
observ
pathogen
includ
hrv
infect
common
previous
document
hmpv
frequent
asymptomat
group
patient
includ
major
rhinovirus
infect
due
hrvc
strain
data
shown
respiratori
syndrom
inde
common
transplant
recipi
transplant
patient
suffer
sporad
episod
upper
respiratori
symptom
recent
suggest
howev
sinc
symptomat
also
asymptomat
viral
infect
trigger
acut
reject
oblit
bronchiol
lung
transplant
recipi
role
new
hev
need
clearli
elucid
result
even
partial
genom
sequenc
analyz
larger
cohort
may
need
suggest
variant
circul
differenti
differ
lineag
worldwid
associ
ard
infant
hematopoiet
stem
cell
transplant
recipi
although
initi
observ
conclus
pathogen
potenti
novel
strain
alway
wider
panel
potenti
pathogen
may
need
continu
monitor
immunocompromis
patient
better
epidemiolog
character
respiratori
infect
infant
present
studi
approv
istituto
di
ricovero
e
cura
caratter
scientifico
ircc
policlinico
san
matteo
ethic
committe
inform
consent
obtain
parent
guardian
complianc
helsinki
declar
consent
publish
individu
clinic
data
tabl
pediatr
sampl
total
archiv
nasopharyng
aspir
npa
children
month
old
hospit
ard
mainli
bronchiol
pneumonia
bronchiti
bronchospasm
wheez
examin
present
studi
sampl
collect
octob
novemb
microbiolog
laboratori
azienda
ospedaliera
melegnano
sampl
collect
period
part
previou
studi
character
infect
human
respiratori
syncyti
viru
hrsv
respiratori
virus
identifi
recent
infant
ard
case
npa
collect
part
standard
diagnost
practic
assess
presenc
hrsv
clinic
data
includ
comorbid
subsequ
bacteri
infect
durat
hospit
presenc
hypoxia
fever
gastrointestin
symptom
time
diagnosi
also
avail
infant
transplant
recipi
sampl
total
archiv
npa
obtain
allogen
autolog
haematopoiet
stem
cell
transplant
recipi
patient
recruit
divis
hematolog
ircc
policlinico
san
matteo
pavia
itali
regardless
respiratori
symptom
describ
respiratori
sampl
consecut
obtain
inform
consent
octob
april
one
nine
sampl
patient
collect
everi
day
day
transplant
time
point
clinic
data
record
sampl
extract
use
qiagen
rna
mini
kit
qiagen
germani
accord
manufactur
protocol
investig
preval
children
haematopoiet
stem
cell
transplant
recipi
patient
specif
primer
target
utr
region
use
f
gac
tgg
agc
aac
tag
taa
gaa
cat
ttc
caa
ttt
cct
better
character
novel
hev
strain
region
also
amplifi
use
follow
primer
gca
tci
ggi
ari
ttc
cac
cac
cc
ggg
acc
aac
tac
ttt
ggg
tgt
ccg
tgt
figur
sensit
amplif
protocol
determin
clone
amplifi
target
region
plasmid
vector
ta
clone
kit
invitrogen
serial
dilut
copi
copi
previous
describ
amplif
protocol
ensur
detect
dna
copiesreact
target
region
respect
data
shown
agaros
gel
electrophoresi
visual
amplif
product
sequenc
bidirect
confirm
amplif
specif
molecular
identif
type
posit
sampl
perform
mega
softwar
clastalw
align
manual
sequenc
edit
bioedit
phylogenet
relationship
estim
use
mega
neighborjoin
method
use
tajimanei
model
estim
use
modeltest
valu
use
mega
previous
estim
directli
data
use
paup
sinc
multipl
infect
frequent
detect
respiratori
sampl
patient
respiratori
symptom
better
clarifi
pathogenet
role
novel
enteroviru
coinfect
specimen
posit
also
assay
presenc
respiratori
virus
includ
parainfluenza
virus
piv
influenza
b
virus
human
metapneumoviru
hmpv
human
respiratori
syncyti
viru
hrsv
adenovirus
human
coronavirus
hcov
human
bocaviru
hbov
wu
wupyv
ki
kipyv
polyomavirus
use
multiplex
pcr
strategi
seeplex
ace
detect
seegen
rockvil
hous
protocol
presenc
human
rhinovirus
hrv
posit
sampl
infant
sampl
immunosuppress
patient
also
investig
molecular
analysi
phylogenet
reconstruct
sampl
subject
first
round
one
step
revers
transcript
amplif
superscriptiii
one
step
rtpcr
platinum
taq
invitrogen
rna
extract
use
primer
caa
gca
ctt
ctg
tyw
ccc
c
acg
gac
acc
caa
agt
ag
follow
thermal
profil
min
min
follow
touchdown
cycl
step
interv
cycl
final
extent
step
first
rtpcr
reaction
underw
seminest
amplif
use
platinum
taqdna
polimeras
invitrogen
forward
primer
three
revers
primer
tta
gcc
aca
ttc
agg
ggc
tta
gcc
aca
ttc
agg
agc
c
tta
gcc
gca
ttc
agg
gg
describ
previous
minor
modif
amplif
protocol
primer
use
final
concentr
nm
amplif
specif
confirm
sequenc
phylogenet
intern
control
use
exclud
contamin
sinc
amplif
protocol
amplifi
also
homolog
target
sequenc
coinfect
sampl
amplif
product
gel
electrophoresi
data
shown
individu
gel
extract
use
qiagen
mini
elut
gel
extract
kit
sequenc
confirm
amplif
specif
hrv
sampl
visual
gel
nest
amplif
product
bp
observ
coinfect
sampl
instead
amplif
reaction
addit
bp
band
inde
alway
present
sequenc
independ
correspond
genom
amplifi
outer
primer
exclud
deeper
clonal
analys
band
would
demonstr
presenc
virus
amplif
product
howev
monoinfect
transplant
recipi
patient
inner
amplif
product
correspond
hev
sequenc
author
declar
compet
interest
erc
ms
rb
ap
perform
experi
epa
collect
sampl
mc
md
fc
analyz
data
fc
md
wrote
draft
author
read
approv
final
manuscript
